MAYO CLINIC
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1889-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mayoclinic.org
Patient Registry in Patients Undergoing Contrast-Enhanced Harmonic Endoscopic Ultrasound Imaging
Completed
- Conditions
- Hematopoietic and Lymphoid System NeoplasmMalignant Solid Neoplasm
- Interventions
- Other: Electronic Health Record Review
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 4
- Registration Number
- NCT05717101
- Locations
- 🇺🇸
Mayo Clinic in Florida, Jacksonville, Florida, United States
Aerosolized Sargramostim Added to Immunotherapy for the Treatment of Patients With Metastatic Melanoma to the Lung
Phase 1
Suspended
- Conditions
- Clinical Stage IV Cutaneous Melanoma AJCC v8Metastatic Malignant Neoplasm in the LungMetastatic MelanomaRecurrent MelanomaUnresectable Melanoma
- Interventions
- Biological: Aerosol SargramostimProcedure: Biospecimen CollectionProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingOther: Medical Device Usage and EvaluationBiological: Nivolumab
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT05717140
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Intratumoral Extracellular Metabolic Impact of DFMO and AMXT 1501 in Patients With Diffuse or High Grade Glioma
Early Phase 1
Recruiting
- Conditions
- Diffuse GliomaMalignant Glioma
- Interventions
- Procedure: Biospecimen CollectionProcedure: Computed TomographyDrug: EflornithineProcedure: Magnetic Resonance ImagingDrug: Polyamine Transport Inhibitor AMXT-1501 DicaprateProcedure: ResectionDevice: MicrodialysisProcedure: Placement
- First Posted Date
- 2023-02-08
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 15
- Registration Number
- NCT05717153
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study of Plant-based Diet on Postprandial Sleepiness
Not Applicable
Completed
- Conditions
- Drowsiness
- Interventions
- Behavioral: Plant-based diet
- First Posted Date
- 2023-01-31
- Last Posted Date
- 2023-06-13
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 12
- Registration Number
- NCT05706649
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
Long Term Followup of Patients Enrolled in MC1137, BEAUTY Study
Recruiting
- Conditions
- Breast Carcinoma
- Interventions
- Procedure: Biospecimen CollectionOther: Questionnaire Administration
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 140
- Registration Number
- NCT05703399
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
3D Ultrasound for the Imaging of Lymph Nodes in Patients With Breast Cancer
Early Phase 1
Recruiting
- Conditions
- Breast Carcinoma
- Interventions
- Device: Ultrasound Imaging
- First Posted Date
- 2023-01-30
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 80
- Registration Number
- NCT05704283
- Locations
- 🇺🇸
Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study to Analyze the Role of Sympathetic Nervous System in Spontaneous Coronary Artery Dissection
Not Applicable
Recruiting
- Conditions
- HealthySpontaneous Coronary Artery Dissection
- Interventions
- Other: Arterial TonometryDiagnostic Test: EchocardiogramDiagnostic Test: Carotid UltrasoundsDiagnostic Test: ElastographyOther: Ankle-Brachial IndexOther: Microneurography with sympathoexcitatory maneuvers
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2024-06-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 50
- Registration Number
- NCT05699200
- Locations
- 🇺🇸
Mayo Clinic Rochester, Rochester, Minnesota, United States
IV SafeLock Device Functionality in Emergency Department
Not Applicable
Completed
- Conditions
- Intravenous Access
- Interventions
- Device: IV SafeLock
- First Posted Date
- 2023-01-23
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 20
- Registration Number
- NCT05695183
- Locations
- 🇺🇸
Mayo Clinic Florida, Jacksonville, Florida, United States
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations
Phase 2
Recruiting
- Conditions
- Castration-Resistant Prostate CarcinomaMetastatic Prostate AdenocarcinomaStage IVB Prostate Cancer AJCC V8
- Interventions
- Drug: Abiraterone Acetate/NiraparibProcedure: Biospecimen CollectionProcedure: Bone ScanProcedure: Computed TomographyProcedure: Magnetic Resonance ImagingDrug: Prednisone
- First Posted Date
- 2023-01-18
- Last Posted Date
- 2024-12-27
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 30
- Registration Number
- NCT05689021
- Locations
- 🇺🇸
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
🇺🇸Mayo Clinic in Florida, Jacksonville, Florida, United States
🇺🇸Mayo Clinic in Rochester, Rochester, Minnesota, United States
A Study of Emergency Department AI Prediction Impact
Completed
- Conditions
- Length of StayHospital Admission
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Mayo Clinic
- Target Recruit Count
- 80
- Registration Number
- NCT05683899
- Locations
- 🇺🇸
Mayo Clinic Minnesota, Rochester, Minnesota, United States
© Copyright 2025. All Rights Reserved by MedPath